Drug Search Results
More Filters [+]

BMG-0703

Alternative Names: BMG-0703, BMG 0703, BMG0703
Latest Update: 2023-05-03
Latest Update Note: Clinical Trial Update

Product Description

Perhyal rinse. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT05787600?term=BMG0703&draw=2&rank=4)

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: University of Milan
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BMG-0703

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Gingivitis|Tooth, Impacted|Gingival Hemorrhage|Periodontitis|Periodontal Pocket|Gingival Pocket|Periodontal Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT05787600

P3

Completed

Gingivitis|Periodontal Diseases

2023-04-20

Orto_BMG0703_WIS_June_2020

P3

Unknown status

Tooth, Impacted

2020-07-01

BMG0703_ORC_May 2019 v.0

P3

Unknown status

Gingivitis

2020-07-01

Orto_BMG0703_PRD_June_2020

P3

Unknown status

Gingival Pocket|Periodontal Pocket|Gingival Hemorrhage|Periodontitis

2020-07-01

Recent News Events

Date

Type

Title